Patient‐reported outcomes for older adults on CamAPS FX closed loop system
Diabetic Medicine · 2023-09 · 40 (9)
DOI: 10.1111/dme.15126 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diabetic Medicine, online erschienen am 23.05.2023. Verfasst von A K Schneider-Utaka und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Diabetes, Stanford Diabetes Research Center, University, Stanford, California, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: NIDDK NIH HHS, Department of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Aims
Use of the CamAPS FX hybrid closed loop (CL) system is associated with improved time in range and glycated haemoglobin A1c across the age span, but little is known about its effects on patient‐reported outcomes (PROs).
Methods
This open‐label, randomized, multi‐site study compared CamAPS FX to sensor‐augmented pump (SAP) in a sample of older adults (≥60 years) with type 1 diabetes (T1D). Thirty‐five older adults completed PROs surveys at the start of the study and after each period of 16 weeks using either CL or SAP. At the end of the study, 19 participated in interviews about their experiences with CL.
Results
Results examining the 16 weeks of CL use showed that the overall Diabetes Distress Scale score and two subscales (powerlessness and physician distress) improved significantly along with trust on the Glucose Monitoring Satisfaction Survey. User experience interview responses were consistent in noting benefits of ‘improved glycaemic control’ and ‘worrying less about diabetes’.
Conclusion
In this sample of older adults with T1D who have previously shown glycaemic benefit, there are indicators of improved PROs and subjective user experience benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Diabetes, Stanford Diabetes Research Center, University, Stanford, California, USA.
- Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
- Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
ORCID-Profile: A K Schneider-Utaka, C K Boughton, H Thabit, J K Mader, P Narendran, R Hovorka
Förderung
- NIDDK NIH HHS
- Department of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Juvenile Diabetes Research Foundation International
Zitieren
APA
Schneider-Utaka, A. K., Hanes, S., Boughton, C. K., Hartnell, S., Thabit, H., Mubita, W. M., Draxlbauer, K., Poettler, T., Hayes, J., Wilinska, M. E., Mader, J. K., Narendran, P., Leelarathna, L., Evans, M. L., Hovorka, R., & Hood, K. K. (2023). Patient‐reported outcomes for older adults on CamAPS FX closed loop system. Diabetic Medicine, 40(9). https://doi.org/10.1111/dme.15126
Vancouver
Schneider-Utaka AK, Hanes S, Boughton CK, Hartnell S, Thabit H, Mubita WM, et al. Patient‐reported outcomes for older adults on CamAPS FX closed loop system. Diabetic Medicine. 2023;40(9). doi:10.1111/dme.15126
BibTeX
@article{SchneiderUtaka2023,
author = {Schneider-Utaka, A K and Hanes, S and Boughton, C K and Hartnell, S and Thabit, H and Mubita, W M and Draxlbauer, K and Poettler, T and Hayes, J and Wilinska, M E and Mader, J K and Narendran, P and Leelarathna, L and Evans, M L and Hovorka, R and Hood, K K},
title = {Patient‐reported outcomes for older adults on CamAPS FX closed loop system},
journal = {Diabetic Medicine},
year = {2023},
volume = {40},
number = {9},
doi = {10.1111/dme.15126}
}
EUVIMED